SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-052002
Filing Date
2020-09-24
Accepted
2020-09-24 19:21:31
Documents
2
Period of Report
2020-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5518
2 POA DOCUMENT poa.txt EX-24.3_938641 3800
  Complete submission text file 0001209191-20-052002.txt   10733
Mailing Address 36 TERRELL DRIVE WASHINGTON CROSS PA 18977
Business Address
Mauro David J (Reporting) CIK: 0001621172 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39527 | Film No.: 201196470

Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences